Dr. Andrew Huberman discusses the chemical and structural similarities between psilocybin and serotonin, their effects on the brain, the specific role of the serotonin 2A receptor in psilocybin's actions, and its potential therapeutic benefits in treating mood disorders and inducing neuroplasticity. Dr. Andrew Huberman is a tenured professor of neurobiology and ophthalmology at Stanford University School of Medicine and host of the Huberman Lab podcast. Watch the full episode: https://www.youtube.com/watch?v=eIxVfln02Ss Show notes: https://www.hubermanlab.com/episode/how-psilocybin-can-rewire-our-brain-its-therapeutic-benefits-and-its-risks Social & Website Instagram: https://www.instagram.com/hubermanlab Threads: https://www.threads.net/@hubermanlab Twitter: https://twitter.com/hubermanlab Facebook: https://www.facebook.com/hubermanlab TikTok: https://www.tiktok.com/@hubermanlab LinkedIn: https://www.linkedin.com/in/andrew-huberman Website: https://www.hubermanlab.com/ Newsletter: https://www.hubermanlab.com/newsletter #HubermanLab #Science The Huberman Lab podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.